AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $8,218,000 | +19.1% | 491,790 | +2.8% | 0.39% | -10.2% |
Q1 2020 | $6,898,000 | -64.9% | 478,343 | -18.6% | 0.43% | -46.2% |
Q4 2019 | $19,662,000 | +59.8% | 587,464 | 0.0% | 0.80% | +47.3% |
Q3 2019 | $12,301,000 | -24.0% | 587,464 | -24.4% | 0.54% | -15.2% |
Q2 2019 | $16,176,000 | -6.8% | 776,943 | 0.0% | 0.64% | -7.6% |
Q1 2019 | $17,365,000 | +11.9% | 776,943 | +19.7% | 0.70% | -4.0% |
Q4 2018 | $15,522,000 | +23.3% | 648,929 | +40.6% | 0.72% | +70.6% |
Q3 2018 | $12,591,000 | +17.9% | 461,549 | +16.2% | 0.42% | +9.8% |
Q2 2018 | $10,678,000 | -15.7% | 397,082 | -0.2% | 0.39% | -22.0% |
Q1 2018 | $12,663,000 | -15.7% | 397,831 | +0.2% | 0.50% | -16.9% |
Q4 2017 | $15,018,000 | +34.1% | 397,082 | -12.1% | 0.60% | +27.8% |
Q3 2017 | $11,197,000 | +18.6% | 451,660 | -1.6% | 0.47% | +13.3% |
Q2 2017 | $9,440,000 | -5.4% | 459,160 | 0.0% | 0.41% | -9.6% |
Q1 2017 | $9,978,000 | -19.6% | 459,160 | -24.4% | 0.46% | -22.8% |
Q4 2016 | $12,418,000 | +98.0% | 607,256 | +45.2% | 0.59% | +85.3% |
Q3 2016 | $6,273,000 | +74.3% | 418,214 | +25.7% | 0.32% | +57.9% |
Q2 2016 | $3,599,000 | -19.3% | 332,625 | +1.2% | 0.20% | -19.2% |
Q1 2016 | $4,457,000 | -14.4% | 328,655 | +16.4% | 0.25% | -9.1% |
Q4 2015 | $5,209,000 | +410.7% | 282,355 | +601.0% | 0.28% | +310.4% |
Q3 2015 | $1,020,000 | – | 40,280 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|